Pharmaceutical

Aprea Therapeutics Announces Presentations at EORTC-NCI-AACR International Conference on Molecular Targets and Therapeutics

DOYLESTOWN, Pa., Oct. 10, 2024 (GLOBE NEWSWIRE) -- Aprea Therapeutics, Inc. (Nasdaq: APRE) (“Aprea”, or the “Company”), a clinical-stage biopharmaceutical company...

Palisade Bio Cleared by Health Canada to Commence Phase 1 Clinical Study for Lead Program, PALI-2108 for the Treatment of Ulcerative Colitis (UC)

– Company has received a No Objection Letter from Health Canada in response to submission of its Phase 1 Clinical...

The Automated Industrial Quality Control (QC) Market is projected to grow by USD 269.5 million (2024-2028), driven by the need for accuracy in quality control, with AI redefining the market landscape – Technavio

Every Cure Receives Five-Year, $60 Million Commitment Through TED’s Audacious Project to Repurpose Medications for Global Impact

PHILADELPHIA, Oct. 9, 2024 /PRNewswire/ -- Every Cure, an AI-powered nonprofit biotech organization, has received a five-year $60 million commitment through...

error: Content is protected !!